Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?

Eur J Pediatr. 2007 Nov;166(11):1187-8. doi: 10.1007/s00431-006-0370-2. Epub 2006 Dec 12.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Anthracyclines / adverse effects*
  • Anthracyclines / therapeutic use
  • Cardiomyopathy, Dilated / chemically induced*
  • Cardiomyopathy, Dilated / prevention & control
  • Cardiovascular Agents / therapeutic use
  • Child
  • Female
  • Heart / drug effects*
  • Humans
  • Male
  • Razoxane / therapeutic use
  • Risk Factors

Substances

  • Anthracyclines
  • Cardiovascular Agents
  • Razoxane